|
|
|
Corporate Profile: Amunix
| Summary: |
| The primary focus of Amunix is the design and early development of protein pharmaceuticals with an extended serum half-life, which may require less frequent administration. |
| Address (HQ): |
500 Ellis Street
Mountain View, CA 94043 |
| Phone #'s (HQ): |
| Main |
(650) 428-1800 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
hr@amunix.com |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
